It is notable that gene therapy approaches for Friedreich’s ataxia involving frataxin overexpression have shown toxicity in mouse studies36,37 and paradoxically cause Fe–S cluster deficiency dependent on frataxin binding to NFS1 (ref. 37). Here, FXN is linked to Friedreich ataxia.